Postoperative analgesic efficacy of continuous wound infusion with local anesthetics after laparoscopy (PAIN): a randomized, double-blind, placebo-controlled trial

Background To investigate the efficacy of continuous wound infusion (CWI) with local anesthetics for reducing postoperative pain compared with placebo in patients undergoing benign gynecologic laparoscopy. Methods In this double-blind trial, 66 patients were randomly assigned to receive either ropivacaine or normal saline though a multi-orifice catheter placed into the umbilical surgical wound for 50 h postoperatively. The primary outcome measure was the severity of postoperative pain 1, 6, 12, 24, and 48 h after surgery. The secondary outcome measure was the number of rescue analgesics requested. Results Baseline characteristics did not statistically differ between the ropivacaine and placebo groups. The intensity of postoperative pain was significantly lower in the ropivacaine group than in the placebo group 1, 6, 12, 24, and 48 h after surgery (all P < 0.05). The number of rescue analgesics requested was also significantly lower in the ropivacaine group than in the placebo group. There were no significant differences between the two groups regarding other surgical outcomes. Conclusion CWI with local anesthetics after laparoscopic surgery provides good analgesia and reduces rescue analgesics consumption..

Medienart:

Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

Surgical endoscopy - 35(2020), 2 vom: 13. Feb., Seite 562-568

Sprache:

Englisch

Beteiligte Personen:

Lee, Nae Hyun [VerfasserIn]
Ryu, Kyoungho [VerfasserIn]
Song, Taejong [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Continuous wound infusion
Laparoendoscopic single-site surgery
Laparoscopy
Pain management
Postoperative pain

Anmerkungen:

© Springer Science+Business Media, LLC, part of Springer Nature 2020

doi:

10.1007/s00464-020-07416-8

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2122949945